Browse by intervention

Statin family: what it changed, and what it did not

One intervention, every measured benefit and result that did not improve in Issue 01. See who it moved for, where it stayed neutral or went the other way, and the next hypothesis Phoenix can validate.

Research issue
Issue 01
Data through
2026-08-09
Evidence map version
v1.1.0

How to read this

Phoenix research is longitudinal and observational: we follow real APOE4 carriers over time and compare each member with their own earlier self, with no placebo group, no randomisation, and members choosing their own interventions.

That means these are strong signals pointing at what to test next, not proof of cause. Most nutrition, supplement and lifestyle research you read online has exactly the same design. The difference is that we say so, and we show you the confounders.

Read the full methods and limits

What the Phoenix community is measuring

Browse exact outcomes and interventions. Each result keeps its source, measurement rule and audit record beside the claim.

Statin family evidence dossier

Evidence collected through 2026-08-09.

Most promising

Apolipoprotein B

Laboratory apolipoprotein B result · Aim: lower

Statin family

Positive individual result

The ApoB Ace lowered ApoB from 98 to 59 mg/dL in 77 days; generic and named statin use counts are not summed.

Selected member cases

  1. ApoB Ace · APOE3/4 · female · age 60-69

    98 → 59 mg/dL · -39.8% · 77 days

    What else changed: no nearby starts were recorded.

    Next study: repeat Apolipoprotein B after a dated Statin family window.

1 selected member case · not a response rate

Logged members
1
Members with repeats
1
Observations
1
Measurements
2
Sources and context

Curated statin-family cases with a dated start and repeat ApoB result.

  • report-lines-215-245, reviewed by independent verifier

1 selected case shown with this evidence.

LDL cholesterol

Laboratory LDL cholesterol result · Aim: lower

Statin family

Positive individual result

The ApoB Ace's longer arc moved LDL cholesterol from 161 to 49 mg/dL, about 70% lower; the aggregate statin effect remains unresolved.

Selected member cases

  1. ApoB Ace · APOE3/4 · female · age 60-69

    LDL cholesterol fell from 161 to 49 mg/dL across nearly one year; exact elapsed days were not printed.

    What else changed: no nearby starts were recorded.

    Next study: repeat LDL cholesterol after a dated Statin family window.

1 selected member case · not a response rate

Logged members
1
Members with repeats
1
Observations
1
Measurements
2
Sources and context

Curated statin-family cases with repeat LDL cholesterol; overlapping catalogue use counts and aggregate cohorts are excluded.

  • report-lines-215-245, reviewed by independent verifier

1 selected case shown with this evidence.

Total cholesterol

Laboratory total cholesterol result · Aim: lower

Statin family

Positive individual result

The ApoB Ace's total cholesterol fell 41.6% in the longer statin arc; paired values and exact elapsed days were not printed.

Selected member cases

  1. ApoB Ace · APOE3/4 · female · age 60-69

    Total cholesterol fell 41.6% in the longer statin arc; paired values and exact elapsed days were not printed.

    What else changed: no nearby starts were recorded.

    Next study: repeat Total cholesterol after a dated Statin family window.

1 selected member case · not a response rate

Logged members
1
Members with repeats
1
Observations
1
Measurements
2
Sources and context

Curated statin-family cases with repeat total cholesterol.

  • report-lines-215-245, reviewed by independent verifier

1 selected case shown with this evidence.

Keep the map

Take every result into your next experiment.

Get the Issue 01 Evidence Map by email. It groups the same evidence by outcome and by intervention, including what worked, what did not, and what Phoenix wants to test next.

Instant PDF · Issue 02 lands in your inbox the day it publishes · No spam

Turn evidence into your next test

Magnesium and homocysteine is 7 members from an answer.

Forty carriers with a dated start and a repeat blood test close it. Creatine, vitamin D3 and B12 sit further back. Your next blood test is somebody else's answer, and theirs is yours.

Take the 7-minute assessment